1 Min Read
April 6 (Reuters) - PHARMANUTRA SPA:
* OBTAINS PATENT FOR CETILAR RM WHICH WILL LAST UNTIL 2035 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.